Renalytix plc - RNLXY

Sector: Healthcare · Industry: Services-Medical Laboratories
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2024 · Q2 2024
Value (USD)
Total reported value ($000)
$595K
QoQ value delta ($000)
+$149K (+33.41%)
Implied price effect (QoQ)
+22.06%
Shares
Total shares
2,137,004
QoQ shares delta
+181,788 (+9.3%)
Total shares held by funds (by quarter)

Market chart (RNLXY)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2024)

Top 25 only Full list
Early Q3 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
PINNACLE ASSOCIATES LTD 330 846,534 0.01%
STIFEL FINANCIAL CORP 102 489,431 0.0%
Corient Private Wealth LLC 70 335,514 0.0%
UBS Group AG 58 279,743 0.0%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 13 63,739 0.0%
GEODE CAPITAL MANAGEMENT, LLC 11 53,311 0.0%
XTX Topco Ltd 4 20,197 0.0%
LPL Financial LLC 3 18,375 0.0%
CITADEL ADVISORS LLC 2 13,700 0.0%
OSAIC HOLDINGS, INC. 2 10,685 0.0%
WELLS FARGO & COMPANY/MN 0 3,400 0.0%
MORGAN STANLEY 0 2,200 0.0%
GROUP ONE TRADING LLC 0 174 0.0%
JPMORGAN CHASE & CO 0 1 0.0%